India’s economy may be struggling, but its pharmaceutical industry is booming, thanks to initiatives to improve domestic access to medicine and a solid export market. But can such growth continue?
The UK lags behind other countries in getting the right treatments to rare disease patients, but promising developments are underway in a bid to help improve access
How an ongoing pricing battle between the NHS and an American biopharmaceutical giant led to a buyers’ club for cystic fibrosis drugs in the UK
Current methods to determine the right value for orphan drugs remain controversial, yet the fast-tracking of new therapies marks a big step forward for the industry
Chronic pain is on the rise, and yet there is still no silver bullet to treat this little-understood area of healthcare
Despite last year’s change in the law legalising the supply of medical cannabis, NHS patients in need are still being refused prescriptions
Pharmacists are becoming the first port of call for patients with minor illnesses as internet pharmacies take a greater share of dispensing drugs and GPs complain of increasing pressure
Manufactured when an original biologic drug’s patent expires, biosimilars can increase access to treatment options and improve patient outcomes